Kai Yang, Zishu Guan, Shihe Guan, Yufeng Gao, Qiang Zhou
Clin Lab. 2016 Nov 1;62(11):2197-2202. doi: 10.7754/Clin.Lab.2016.160420.
Hepatitis B virus (HBV) infection represents a major threat to global public health, especially in China. The clear pathogenesis of chronic HBV infection (CHB) has not been fully elucidated, but inflammation is widely accepted to play an important role. Emerging evidence suggests that red blood cell distribution (RDW) is a novel potential marker of inflammatory responses. The present study aimed to investigate the clinical relevance of elevated RDW in the patients with chronic HBV liver disease ICP.
A total of 731 individuals with chronic HBV liver disease, comprising 92 CHB patients, 606 patients with HBV-related liver cirrhosis (LC), and 33 patients with hepatocellular carcinoma (HCC). Fifty volunteers represented the healthy controls (HC). Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), total bilirubin (Tbil), albumin (Alb), prothrombin time (PT), and RDW were tested. Correlations between RDW and other clinical parameters were analyzed. A multivariable logistic regression model and the receiver operating characteristic (ROC) curve were used in the analysis of RDW as a predictor of 3-month mortality in the patients with decompensated liver cirrhosis.
Our results showed that RDW was significantly increased in patients with chronic HBV liver disease, except for CHB patients. Moreover, RDW was positively correlated with ALP and PT and negatively correlated with Alb in patients with chronic HBV liver disease. A multivariable logistic regression model showed that RDW was an independent predictor of 3-month mortality in the patients with decompensated liver cirrhosis (odds ratio [OR]: 1.345, 95% confidence interval [CI]: 1.200 - 1.506, p= 0.000). Based on the receiver operating characteristic (ROC) curve, use of RDW as an independent predictor of 3-month mortality was projected to be 17.15%, and yielded a sensitivity and specificity of 92.16% and 66.49%, respectively, with an area under the curve of 0.799 (95% CI: 0.746 - 0.838).
These data suggest that RDW may be a useful indicator to assess the liver function in patients with chronic HBV liver disease and help to predict mortality in hospitalized patients with decompensated cirrhosis in patients.
乙型肝炎病毒(HBV)感染是全球公共卫生的重大威胁,在中国尤为如此。慢性HBV感染(CHB)的确切发病机制尚未完全阐明,但炎症被广泛认为起着重要作用。新出现的证据表明,红细胞分布宽度(RDW)是炎症反应的一种新的潜在标志物。本研究旨在探讨慢性HBV肝病合并肝内胆汁淤积(ICP)患者RDW升高的临床相关性。
共有731例慢性HBV肝病患者,包括92例CHB患者、606例HBV相关肝硬化(LC)患者和33例肝细胞癌(HCC)患者。50名志愿者作为健康对照(HC)。检测丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、碱性磷酸酶(ALP)、总胆红素(Tbil)、白蛋白(Alb)、凝血酶原时间(PT)和RDW。分析RDW与其他临床参数之间的相关性。采用多变量逻辑回归模型和受试者工作特征(ROC)曲线分析RDW作为失代偿期肝硬化患者3个月死亡率预测指标的价值。
我们的结果显示,除CHB患者外,慢性HBV肝病患者的RDW显著升高。此外,慢性HBV肝病患者的RDW与ALP和PT呈正相关,与Alb呈负相关。多变量逻辑回归模型显示,RDW是失代偿期肝硬化患者3个月死亡率的独立预测指标(比值比[OR]:1.345,95%置信区间[CI]:1.200 - 1.506,p = 0.000)。根据受试者工作特征(ROC)曲线,将RDW用作3个月死亡率的独立预测指标的预测值为17.15%,敏感性和特异性分别为92.16%和66.49%,曲线下面积为0.799(95%CI:0.746 - 0.838)。
这些数据表明,RDW可能是评估慢性HBV肝病患者肝功能的有用指标,并有助于预测失代偿期肝硬化住院患者的死亡率。